Skip to content

68Ga PET/CT versus 99mTc SPECT/CT for lung perfusion and ventilation scintigraphy; a technical and practical feasibility study

68Ga PET/CT versus 99mTc SPECT/CT for lung perfusion and ventilation scintigraphy; a technical and practical feasibility study - GaTcha

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53981
Enrollment
20
Registered
2023-02-01
Start date
2023-03-28
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary embolisms

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult >=18 years and declared competent - Provided written informed consent - Referred to the Nuclear Medicine Department for a conventional V/Q-SPECT/CT - Indication for conventional V/Q-SPECT/CT includes known or suspected pulmonary embolism

Exclusion criteria

Exclusion criteria: - Pregnancy - Children or adolescents (

Design outcomes

Primary

MeasureTime frame
Investigate and define optimal image acquisition parameters for V/Q PET/CT. Within the two patient groups, different technical parameters will be applied during image acquisition and post-processing. After enrolment of the final participant (#20) and image acquisition, all imaging studies will be presented to two independent nuclear medicine physicians, for a blinded assessment, presented in a random order. During the first assessment round; Independent physicians should grade subjective image quality according to a five-point Likert scale (ranging from very poor to very good). During a second assessment round; Independent physicians should grade image quality, compared to the current clinical standard (V/Q-SPECT). Finally, in the same round as the second assessment, physicians should report whether or not additional perfusion and/or ventilation defects could be acknowledged. Besides subjective image quality assessment, (semi-)quantitative measurement will be performed by a medical physicist (e.g. signal-to-noise ratio, etc.)

Secondary

MeasureTime frame
Confirm feasibility of 68Ga-MAA and Galligas (preparation for administration and administration at the aimed time points). This will be derived from the radionuclide pharmacy (RNA) log and weekly radiopharmaceutical meetings within the department. Confirm logistical advantages of 68Ga-V/Q-PET/CT over 99mTc-V/Q-SPECT/CT. Differences in total acquisition times will be gathered and compared by a simple two-sided t-test; total scanning time per separate procedure (99mTc-MAA/99mTechnegas/68Ga-MAA/68Galligas) and a combination of scans (V/Q-SPECT/CT vs V/Q-PET/CT). Additionally, total procedure time will be gathered and compared in a similar fashion. Registration of both acquisition times and procedure times are standard practice and can be directly derived from the imaging archive (Sectra PACS) or medical record files (HiX, Chipsoft).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026